Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 12656
Country/Region: Kenya
Year: 2014
Main Partner: Eastern Deanery AIDS Relief Program
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $6,769,188 Additional Pipeline Funding: $194,190

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Eastern Deanery AIDS Relief Program (EDARP) is a local faith based organization based in the eastern slums of Nairobi whose goal is to reduce the incidence of HIV and TB and improve the quality of life through effective care, treatment, and prevention interventions to a population of 2,157,960 whose estimated adult HIV prevalence of 5.2% using a community based model. Program goals and objectives are linked to Kenya’s Partnership Framework (PF) and Global Health Initiative strategies and directly aligned to PF pillars 1-3, prevention, care and mitigation, treatment, and systems strengthening. Strategies to reduce maternal and child mortality and eliminate MTCT include family planning integration into HIV clinics.

EDARP will ensure cost efficiency through service integration, use of evidence-based strategies, task shifting, implementation of facility-based training and mentorship as opposed to offsite training, and innovative strategies for defaulter tracking and laboratory networking. EDARP will strengthen continuous quality monitoring through mentorship of trained health care workers, and use of multi-disciplinary and inter-facility grand rounds for best practice sharing.

EDARP will partner with the MOH in various aspects of the HIV program including capacity-building strategies aimed at strengthening sustainable local systems for effective transition to local ownership. High quality data collection will be implemented through the use of an electronic medical records (EMR) system which incorporates MOH and PEPFAR indicators ensuring timely and accurate reporting.

EDARP will continue routine cohort analysis to monitor retention of clients. Strengthen monthly facility progress review and data use for decision and improvement of program performance.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $390,988
Care: TB/HIV (HVTB) $751,284
Care: Pediatric Care and Support (PDCS) $133,215
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $363,377
Testing: HIV Testing and Counseling (HVCT) $550,914
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $493,750
Treatment: Adult Treatment (HTXS) $3,788,370
Treatment: Pediatric Treatment (PDTX) $297,290
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 3,308
C2.1.D By Age: 15+ 2015 33,364
C2.1.D By Age/Sex: <15 Female 2015 1,654
C2.1.D By Age/Sex: <15 Male 2015 1,654
C2.1.D By Age/Sex: 15+ Female 2015 22,020
C2.1.D By Age/Sex: 15+ Male 2015 11,344
C2.1.D By Sex: Female 2015 23,674
C2.1.D By Sex: Male 2015 12,998
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 36,672
C2.1.D Sum of Age disaggregates 2015 36,672
C2.1.D Sum of Age/Sex disaggregates 2015 36,672
C2.1.D Sum of Sex disaggregates 2015 36,672
C2.1.D_NGI By Age: <15 2015 3,308
C2.1.D_NGI By Age: 15+ 2015 33,364
C2.1.D_NGI By Age/Sex: <15 Female 2015 1,654
C2.1.D_NGI By Age/Sex: <15 Male 2015 1,654
C2.1.D_NGI By Age/Sex: 15+ Female 2015 22,020
C2.1.D_NGI By Age/Sex: 15+ Male 2015 11,344
C2.1.D_NGI By Sex: Female 2015 23,674
C2.1.D_NGI By Sex: Male 2015 12,998
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 36,672
C2.1.D_NGI Sum of Age disaggregates 2015 36,672
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 36,672
C2.1.D_NGI Sum of Sex disaggregates 2015 36,672
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 36,672
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 34,838
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 36,672
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 697
CARE_CURR Age/sex: <1 Female 2015 54
CARE_CURR Age/sex: <1 Male 2015 54
CARE_CURR Age/sex: 1-4 Female 2015 359
CARE_CURR Age/sex: 1-4 Male 2015 378
CARE_CURR Age/sex: 10-14 Female 2015 498
CARE_CURR Age/sex: 10-14 Male 2015 502
CARE_CURR Age/sex: 15-19 Female 2015 441
CARE_CURR Age/sex: 15-19 Male 2015 267
CARE_CURR Age/sex: 20-24 Female 2015 1,831
CARE_CURR Age/sex: 20-24 Male 2015 495
CARE_CURR Age/sex: 25-49 Female 2015 15,640
CARE_CURR Age/sex: 25-49 Male 2015 7,443
CARE_CURR Age/sex: 5-9 Female 2015 660
CARE_CURR Age/sex: 5-9 Male 2015 638
CARE_CURR Age/sex: 50+ Female 2015 3,007
CARE_CURR Age/sex: 50+ Male 2015 2,571
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,571
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 1,572
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 20,919
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 10,776
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 34,838
CARE_CURR Sum of Age/Sex disaggregates 2015 34,838
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 34,838
CARE_NEW Age/sex: <1 Female 2015 10
CARE_NEW Age/sex: <1 Male 2015 10
CARE_NEW Age/sex: 1-4 Female 2015 65
CARE_NEW Age/sex: 1-4 Male 2015 69
CARE_NEW Age/sex: 10-14 Female 2015 91
CARE_NEW Age/sex: 10-14 Male 2015 91
CARE_NEW Age/sex: 15-19 Female 2015 94
CARE_NEW Age/sex: 15-19 Male 2015 41
CARE_NEW Age/sex: 20-24 Female 2015 175
CARE_NEW Age/sex: 20-24 Male 2015 172
CARE_NEW Age/sex: 25-49 Female 2015 2,627
CARE_NEW Age/sex: 25-49 Male 2015 1,465
CARE_NEW Age/sex: 5-9 Female 2015 120
CARE_NEW Age/sex: 5-9 Male 2015 116
CARE_NEW Age/sex: 50+ Female 2015 908
CARE_NEW Age/sex: 50+ Male 2015 281
CARE_NEW Aggregated Age/sex: <15 Female 2015 286
CARE_NEW Aggregated Age/sex: <15 Male 2015 286
CARE_NEW Aggregated Age/sex: 15+ Female 2015 3,804
CARE_NEW Aggregated Age/sex: 15+ Male 2015 1,959
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 6,335
CARE_NEW Sum of Age/sex disaggregates 2015 6,335
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 6,335
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 14
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 14
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 14
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 14
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 14
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 14
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 13
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 14
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 13
FN_SITE Sum of Numerator Support Type disaggregates 2015 13
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 14
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 14
FN_THER Age: <1 2015 18
FN_THER Age: 1-4 2015 119
FN_THER Age: 15-17 2015 110
FN_THER Age: 18+ 2015 4,883
FN_THER Age: 5-14 2015 371
FN_THER Aggregated Age: <18 2015 618
FN_THER Aggregated Age: 18+ 2015 4,883
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 5,501
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 7,334
FN_THER Sum of Age disaggregates 2015 5,501
FN_THER Sum of Aggregated Age disaggregates 2015 5,501
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 11
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 14
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 11
FPINT_SITE Service delivery type: Clinical 2015 11
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 11
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 11
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 14
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 14
HTS_TST Age/sex: 1-4 Female 2015 8,093
HTS_TST Age/sex: 1-4 Female 2015 8,093
HTS_TST Age/sex: 1-4 Male 2015 8,093
HTS_TST Age/sex: 1-4 Male 2015 8,093
HTS_TST Age/sex: 10-14 Female 2015 5,781
HTS_TST Age/sex: 10-14 Female 2015 5,781
HTS_TST Age/sex: 10-14 Male 2015 5,781
HTS_TST Age/sex: 10-14 Male 2015 5,781
HTS_TST Age/sex: 15-19 Female 2015 11,562
HTS_TST Age/sex: 15-19 Female 2015 11,562
HTS_TST Age/sex: 15-19 Male 2015 11,562
HTS_TST Age/sex: 15-19 Male 2015 11,562
HTS_TST Age/sex: 20-24 Female 2015 28,904
HTS_TST Age/sex: 20-24 Female 2015 28,904
HTS_TST Age/sex: 20-24 Male 2015 28,904
HTS_TST Age/sex: 20-24 Male 2015 28,904
HTS_TST Age/sex: 25-49 Female 2015 46,247
HTS_TST Age/sex: 25-49 Female 2015 46,247
HTS_TST Age/sex: 25-49 Male 2015 46,247
HTS_TST Age/sex: 25-49 Male 2015 46,247
HTS_TST Age/sex: 5-9 Female 2015 3,469
HTS_TST Age/sex: 5-9 Female 2015 3,469
HTS_TST Age/sex: 5-9 Male 2015 3,469
HTS_TST Age/sex: 5-9 Male 2015 3,469
HTS_TST Age/sex: 50+ Female 2015 11,562
HTS_TST Age/sex: 50+ Female 2015 11,562
HTS_TST Age/sex: 50+ Male 2015 11,561
HTS_TST Age/sex: 50+ Male 2015 11,561
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 17,343
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 17,343
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 98,275
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 98,274
HTS_TST Aggregated Age/sex: <15 Female 2015 17,343
HTS_TST Aggregated Age/sex: <15 Male 2015 17,343
HTS_TST Aggregated Age/sex: 15+ Female 2015 98,275
HTS_TST Aggregated Age/sex: 15+ Male 2015 98,274
HTS_TST By Test Result: Negative 2015 221,986
HTS_TST By Test Result: Negative 2015 221,986
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 231,235
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 231,235
HTS_TST Sum of Age/Sex disaggregates 2015 231,235
HTS_TST Sum of Age/Sex disaggregates 2015 231,235
HTS_TST Sum of Aggregated Age/Sex <15 2015 34,686
HTS_TST Sum of Aggregated Age/Sex <15 2015 34,686
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 196,549
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 196,549
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 231,235
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 231,235
HTS_TST Sum of Test Result disaggregates 2015 231,235
HTS_TST Sum of Test Result disaggregates 2015 231,235
HTS_TST_POS By Test Result: Positive 2015 9,249
HTS_TST_POS By Test Result: Positive 2015 9,249
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 7
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 7
LAB_CAP Sum of Site Support Type disaggregates 2015 7
PMTCT_ARV Life-long ART (including Option B+) 2015 910
PMTCT_ARV Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 304
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,214
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,214
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 485
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 425
PMTCT_ARV Sum of New and Current disaggregates 2015 910
PMTCT_ARV Sum of Regimen Type disaggregates 2015 1,214
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 910
PMTCT_ARV_NGI Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 304
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,214
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,214
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 485
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 425
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 910
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 1,214
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 728
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 243
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 49
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 1,214
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 971
PMTCT_EID Sum of Infant Age disaggregates 2015 971
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 14
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 14
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 14
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 14
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 14
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 14
PMTCT_STAT By: Known positives at entry 2015 571
PMTCT_STAT By: Number of new positives identified 2015 643
PMTCT_STAT Number of new ANC and L&D clients 2015 5,002
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 5,002
PMTCT_STAT Sum of Positives Status disaggregates 2015 1,214
PMTCT_STAT_NGI By: Known positives at entry 2015 571
PMTCT_STAT_NGI By: Number of new positives identified 2015 643
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 5,002
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 5,002
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 1,214
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 11
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 14
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 11
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 11
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 14
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 14
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 7
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 14
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 14
SITE_SUPP Number of unique sites supported by PEPFAR 2015 14
TB_ART Age: 0-4 2015 39
TB_ART Age: 15+ 2015 1,423
TB_ART Age: 5-14 2015 106
TB_ART Aggregated Age: <15 2015 145
TB_ART Aggregated Age: 15+ 2015 1,423
TB_ART Female 2015 721
TB_ART Known HIV-positive 2015 627
TB_ART Male 2015 847
TB_ART Newly tested 2015 941
TB_ART Sum of Aggregated Age disaggregates 2015 1,568
TB_ART Sum of Sex disaggregates 2015 1,568
TB_ART Sum of Test Status disaggregates 2015 1,568
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 1,742
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 1,568
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 14
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 14
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 14
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 14
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 14
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 14
TB_SCREEN Age: <1 2015 105
TB_SCREEN Age: 1-4 2015 714
TB_SCREEN Age: 10-14 2015 971
TB_SCREEN Age: 15-19 2015 669
TB_SCREEN Age: 20-24 2015 2,231
TB_SCREEN Age: 25-49 2015 21,917
TB_SCREEN Age: 5-9 2015 1,260
TB_SCREEN Age: 50+ 2015 5,229
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 3,050
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 30,046
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 34,838
TB_SCREEN Sex: Female 2015 21,355
TB_SCREEN Sex: Male 2015 11,741
TB_SCREEN Sum of Age disaggregates 2015 3,719
TB_SCREEN Sum of Aggregated Age disaggregates 2015 33,096
TB_SCREEN Sum of Sex disaggregates 2015 33,096
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 33,096
TX_CURR Age/Sex: <1 Female 2015 44
TX_CURR Age/Sex: <1 Male 2015 44
TX_CURR Age/Sex: 1-4 Female 2015 295
TX_CURR Age/Sex: 1-4 Male 2015 295
TX_CURR Age/Sex: 15+ Female 2015 16,545
TX_CURR Age/Sex: 15+ Male 2015 8,909
TX_CURR Age/Sex: 5-14 Female 2015 922
TX_CURR Age/Sex: 5-14 Male 2015 922
TX_CURR Aggregated Age/Sex: <1 Female 2015 44
TX_CURR Aggregated Age/Sex: <1 Male 2015 44
TX_CURR Aggregated Age/Sex: <15 Female 2015 1,261
TX_CURR Aggregated Age/Sex: <15 Male 2015 1,261
TX_CURR Aggregated Age/Sex: 15+ Female 2015 16,545
TX_CURR Aggregated Age/Sex: 15+ Male 2015 8,909
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 27,976
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 76
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 75
TX_CURR Sum of age/sex disaggregates 2015 2,522
TX_CURR Sum of Aggregated Age/Sex <15 2015 2,522
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 25,454
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 27,976
TX_CURR_NGI Age/Sex: <1 Female 2015 44
TX_CURR_NGI Age/Sex: <1 Male 2015 44
TX_CURR_NGI Age/Sex: 1-4 Female 2015 295
TX_CURR_NGI Age/Sex: 1-4 Male 2015 295
TX_CURR_NGI Age/Sex: 15+ Female 2015 16,545
TX_CURR_NGI Age/Sex: 15+ Male 2015 8,909
TX_CURR_NGI Age/Sex: 5-14 Female 2015 922
TX_CURR_NGI Age/Sex: 5-14 Male 2015 922
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 44
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 44
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 1,261
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 1,261
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 16,545
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 8,909
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 27,976
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 27,976
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 2,522
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 25,454
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 27,976
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 1
TX_DIST Total number of PEPFAR supported District Health Offices 2015 1
TX_NEW Aggregated Grouping by Age: <1 Male 2015 96
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 96
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 320
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 320
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 2,535
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 1,365
TX_NEW Breastfeeding status 2015 42
TX_NEW By Age/Sex: <1 Female 2015 96
TX_NEW By Age/Sex: <1 Male 2015 96
TX_NEW By Age/Sex: 1-4 Female 2015 54
TX_NEW By Age/Sex: 1-4 Male 2015 54
TX_NEW By Age/Sex: 10-14 Female 2015 74
TX_NEW By Age/Sex: 10-14 Male 2015 74
TX_NEW By Age/Sex: 15-19 Female 2015 53
TX_NEW By Age/Sex: 15-19 Male 2015 34
TX_NEW By Age/Sex: 20-24 Female 2015 222
TX_NEW By Age/Sex: 20-24 Male 2015 63
TX_NEW By Age/Sex: 25-49 Female 2015 1,895
TX_NEW By Age/Sex: 25-49 Male 2015 943
TX_NEW By Age/Sex: 5-9 Female 2015 96
TX_NEW By Age/Sex: 5-9 Male 2015 96
TX_NEW By Age/Sex: 50+ Female 2015 364
TX_NEW By Age/Sex: 50+ Male 2015 326
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 4,540
TX_NEW Pregnancy status 2015 382
TX_NEW Sum of Age/Sex disaggregates 2015 4,540
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 4,540
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 97
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 3,550
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 264
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 360
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 3,550
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 3,911
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 758
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 4,601
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 114
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 4,177
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 310
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 424
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 4,177
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 892
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 10
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 14
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 10
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 10
TX_SITE Total number of PEPFAR-supported ART sites 2015 14
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 14
VMMC_AE By AE type: Number of VMMC clients with one or more moderate or severe surgical intra-operative AE(s) 2015 35
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2015 35
VMMC_CIRC By Age: 10-14 2015 2,413
VMMC_CIRC By Age: 15-19 2015 2,383
VMMC_CIRC By Age: 20-24 2015 595
VMMC_CIRC By Age: 25-49 2015 566
VMMC_CIRC By circumcision technique: Surgical VMMC 2015 5,957
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2015 3,291
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 1,772
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 766
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 4,836
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 295
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 5,957
VMMC_CIRC Sum of age disaggregates 2015 5,957
VMMC_CIRC_NGI By Age: 10-14 2015 2,413
VMMC_CIRC_NGI By Age: 15-19 2015 2,383
VMMC_CIRC_NGI By Age: 20-24 2015 595
VMMC_CIRC_NGI By Age: 25-49 2015 566
VMMC_CIRC_NGI By circumcision technique: Surgical VMMC 2015 5,957
VMMC_CIRC_NGI By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2015 3,291
VMMC_CIRC_NGI By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 1,772
VMMC_CIRC_NGI By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 766
VMMC_CIRC_NGI By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 4,836
VMMC_CIRC_NGI By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 295
VMMC_CIRC_NGI Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 5,957
VMMC_CIRC_NGI Sum of Age disaggregates 2015 5,957
Cross Cutting Budget Categories and Known Amounts Total: $2,356,162
Human Resources for Health $1,922,394
Food and Nutrition: Policy, Tools, and Service Delivery $10,000
Equity in HIV prevention, care, treatment and support
Monitoring and Evaluation
Gender: Gender Based Violence (GBV) $174,084
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $174,084
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Motor Vehicles: Purchased $60,600
Condoms: Commodities $15,000
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning